Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02619812 · ClinicalTrials.gov registry record · Phase 2
Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT
A Phase 2 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT02619812: Clinical Trial Phase 2 study, sponsored by Mayo Clinic.
NCT02619812 is a Phase 2 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 4 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02619812, a Phase 2 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
For patients who receive a hematopoietic cell transplant (HCT), there is a risk of developing a diarrhea secondary to the chemotherapy which we give. Diarrhea is usually harmless in healthy adults; however, in transplant patients, diarrhea can result in dehydration, negative impact on quality of life, and prolonged hospitalization. The purpose of this study was to see if Colesevelam (Welchol) and Serum-derived bovine immunoglobulin-protein (SBI) result in a change in the frequency or consistency of your bowel movements.
Primary Outcome
Stool frequency was self reported in a daily bowel pattern diary for 30 days.
Interventions
- DRUG Colesevelam
- OTHER Serum-derived bovine immunoglobulin/protein isolate (SBI)
- OTHER Double Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Why NCT02619812 stopped before completion
NCT02619812 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Colesevelam is the first listed.
NCT02619812 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02619812 about?
NCT02619812 is a clinical study titled "Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT". For patients who receive a hematopoietic cell transplant (HCT), there is a risk of developing a diarrhea secondary to the chemotherapy which we give. Diarrhea is usually harmless in healthy adults; however, in transplant patients, diarrhea can result in dehydration, negative impact on quality of lif...
What is the current status of trial NCT02619812?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2016-04. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02619812?
The interventions under investigation include: Colesevelam (DRUG), Serum-derived bovine immunoglobulin/protein isolate (SBI) (OTHER), Double Placebo (OTHER).
Who is sponsoring clinical trial NCT02619812?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02619812's enrollment target sits among peer trials
4 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia